Author details

Full Name

Daniel Rosebrock

Affiliation

ORCID

Career Start Year

2017

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36624313	Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.	Nat Med	2023
35358998	The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia.	Blood Adv	2023
37653227	Author Correction: Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling.	Nat Biotechnol	2023
37081260	Inferring early genetic progression in cancers with unobtainable premalignant disease.	Nat Cancer	2023
35243413	Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma.	Cell Rep Med	2022
35697781	Enhanced cortical neural stem cell identity through short SMAD and WNT inhibition in human cerebral organoids facilitates emergence of outer radial glial cells.	Nature Cell Biology	2022
32788668	Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling.	Nat Biotechnol	2021
31171663	RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues.	Science	2019
31543463	Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies.	Cancer Cell	2019
31142838	Growth dynamics in naturally progressing chronic lymphocytic leukaemia.	Nature	2019
29162005	On Rhythms in Neuronal Networks with Recurrent Excitation.	Neural Computation	2018
30256787	Mechanisms of acquired resistance to rapalogs in metastatic renal cell carcinoma.	PLoS Genet	2018
30107175	Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in HÃ¼rthle Cell Carcinoma.	Cancer Cell	2018
29955181	Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
29955182	Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
29717118	Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair.	Nat Commun	2018
29713087	Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
29109393	Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.	Nat Commun	2017
29070816	Resistance to checkpoint blockade therapy through inactivation of antigen presentation.	Nat Commun	2017
29259203	The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.	Nat Commun	2017
29872714	Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens.	NPJ Precis Oncol	2017
28825726	A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.	Nat Genet	2017